# An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects

> **NCT00972907** · PHASE1,PHASE2 · COMPLETED · sponsor: **RDD Pharma Ltd** · enrollment: 20 (estimated)

## Conditions studied

- Chronic Anal Fissure

## Interventions

- **DRUG:** Nifedipine coated suppositories

## Key facts

- **NCT ID:** NCT00972907
- **Lead sponsor:** RDD Pharma Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2011-01
- **Final completion:** 2011-02
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00972907

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00972907, "An Open Label Study to Examine the Effect of Coated Nifedipine Suppository on Anal Fissure Pain and Healing in Human Subjects". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00972907. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*